MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$101,931,000
Net Income
$25,988,000
Net Profit Margin
25.50%
EPS
$0.29
Unit: Dollar
Revenue Breakdown
Defen Cath
Melinta Portfolio
Contract Revenue
Grant Income
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-03-31
Total revenue and grant income
101,931,000
127,427,000
-132,252,451*
39,081,657
Cost of sales (exclusive of amortization of intangibles)
14,505,000
12,005,000
17,298,855*
1,596,715
Amortization of intangibles
10,300,000
10,300,000
3,468,000*
-
Gross profit
77,126,000
105,122,000
-153,019,306*
37,484,942
Research and development
6,684,000
7,212,000
9,755,680*
3,192,440
Selling and marketing
12,447,000
12,532,000
24,632,480*
4,473,840
General and administrative
15,085,000
21,720,000
39,139,854*
9,693,382
Total operating expenses
34,216,000
41,464,000
73,528,014*
17,359,662
Income from operations
42,910,000
63,658,000
-226,547,320*
20,125,280
Interest income
-
-
2,145,609*
566,797
Interest expense
-
-
3,604,729*
10,007
Foreign exchange transaction gain
-
-
62,516*
-38,172
Unrealized gain (loss) on marketable equity security
2,546,000
-3,546,000
1,341,000*
-
Change in contingent consideration
-6,652,000
-4,199,000
-1,625,250*
-
Other non-operating (expense) income, net
-71,000
-268,000
-
-
Total other (expense) income
-4,177,000
-8,013,000
-1,680,854*
518,618
Income before income taxes
38,733,000
55,645,000
-228,228,174*
20,643,898
Tax expense
12,745,000
17,044,000
-3,259,750*
-
Net income
25,988,000
38,601,000
-224,968,424
20,643,898
Unrealized loss from investment
-
-
-
-4,511
Foreign currency translation (loss) gain
-
-
-
-1,579
Total other comprehensive loss
-
-
-
-6,090
Other comprehensive income (loss)
-
-
-
-20,637,808
Basic EPS
0.33
0.48
-3.456
0.32
Diluted EPS
0.29
0.43
-3.269
0.3
Basic Average Shares
78,444,000
79,509,000
-65,100,273
65,244,341
Diluted Average Shares
92,479,000
92,985,000
-68,814,802
68,975,418
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Defen Cath
$66,119,000
Melinta Portfolio
$28,222,000
Product
$94,341,000
Contract Revenue
$4,966,000
Grant Income
$2,624,000
Total revenue and
grant income
$101,931,000
Gross profit
$77,126,000
Cost of sales
(exclusive of amortization...
$14,505,000
Amortization of intangibles
$10,300,000
Income from operations
$42,910,000
Total operating
expenses
$34,216,000
Income before income
taxes
$38,733,000
Total other (expense)
income
-$4,177,000
Unrealized gain (loss) on
marketable equity security
$2,546,000
General and
administrative
$15,085,000
Selling and marketing
$12,447,000
Research and development
$6,684,000
Net income
$25,988,000
Tax expense
$12,745,000
Change in contingent
consideration
-$6,652,000
Other non-operating
(expense) income, net
-$71,000
Buy us a coffee
CorMedix Inc. (CRMD)
CorMedix Inc. (CRMD)